| Variscan Mines Limited (VAR) ORDINARY FULLY PAID |
Materials |
$5 |
Rights Issue Results
|
30 Oct 2024 10:34AM |
$0.012 |
$0.007 |
fallen by
41.67%
|
|
VAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Fully underwritten renounceable entitlement offer closed on 23 October 2024.
- Total of $913,130 raised through 130,447,227 ordinary shares applications.
- Eligible shareholders offered two new shares for every three shares held.
- One free attaching new option for every four shares subscribed for.
- Shortfall of 164,885,821 ordinary shares.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Opyl Limited (OPL) ORDINARY FULLY PAID |
Information Technology |
$6 |
Updated Quarterly Activities & Cashflow Report
|
30 Oct 2024 10:34AM |
$0.016 |
$0.025 |
risen by
56.25%
|
|
OPL - Price-sensitive ASX Announcement
Full Release
Key Points
- New Service Agreement with Commercial Eyes to utilize TrialKey's AI-driven platform.
- Partnership with BioIntelect for AI-driven clinical trial design services.
- Collaboration with Alithia Life Sciences to incorporate TrialKey reports.
- Partnership with Phenix Health to offer TrialKey to suppliers in the medicinal cannabis market.
- Increased visibility through international marketing initiatives.
- Biotech Fund partnership aiming to raise $100 million AUD.
- Memorandum of Understanding with Xco Consortium in due diligence phase.
- $700,000 AUD in loans secured for financial stability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cullen Resources Limited (CUL) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities Report
|
30 Oct 2024 10:34AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
CUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling planned to commence in December at Wongan Hills.
- Soil sampling and mapping targeting gold at Barlee scheduled for November.
- Ongoing exploration activities include testing REE anomalies and gold targets.
- Rights issue raised $739,372 during the quarter.
- Cullen holds royalties over iron ore production from various projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capricorn Metals Ltd (CMM) ORDINARY FULLY PAID |
Materials |
$4,163 |
Capital Raising Presentation
|
30 Oct 2024 10:33AM |
$6.310 |
$9.655 |
risen by
53.01%
|
|
CMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Capricorn aims to raise approximately A$200 million through an institutional placement.
- The funds will fully support the development of the Karlawinda Gold Project and Mt Gibson Gold Project.
- CMM plans to avoid additional debt and mandatory gold hedging.
- Key investments include expanding processing capacity at KGP and advancing MGGP.
- The management team has a strong track record in the mining industry.
- MGGP has substantial gold reserves, positioning it for high-margin production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Superior Resources Limited (SPQ) ORDINARY FULLY PAID |
Materials |
$12 |
APPENDIX 5B QUARTERLY CASHFLOW
|
30 Oct 2024 10:33AM |
$0.008 |
$0.005 |
fallen by
33.33%
|
|
SPQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was -$256,000.
- Total cash outflows from investing activities amounted to -$651,000.
- Financing activities generated $1,181,000.
- Cash and cash equivalents at quarter end were $1,129,000.
- Estimated 1.25 quarters of funding available for future operations.
- The board expects to continue operations and raise further cash when needed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Western Exploration Limited (GTE) ORDINARY FULLY PAID |
Materials |
$11 |
Cleansing Statement under S708A
|
30 Oct 2024 10:33AM |
$0.035 |
$0.020 |
fallen by
42.86%
|
|
| Superior Resources Limited (SPQ) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Oct 2024 10:33AM |
$0.008 |
$0.005 |
fallen by
33.33%
|
|
SPQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Scoping Study completed indicating robust economics for toll treatment and stand-alone processing.
- Feasibility Study commenced based on Scoping Study outcomes.
- New gold mineralization zones identified during exploration drilling.
- Government grant of $300,000 awarded for critical minerals exploration.
- Ongoing resource expansion drilling following the identification of new gold shoots.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rubix Resources Limited (RB6) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Oct 2024 10:32AM |
$0.077 |
$0.082 |
risen by
6.49%
|
|
RB6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Induced Polarisation survey completed at Paperbark.
- Three key chargeability targets identified, including one at Grunter North.
- Planning for high-resolution airborne magnetic survey at Redbeds.
- Cash position as of September 30, 2024 was $1.941 million.
- Exploration expenditure for the quarter totaled $190,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IPB Petroleum Limited (IPB) ORDINARY FULLY PAID |
Energy |
$4 |
Notice of Annual General Meeting/Proxy Form
|
30 Oct 2024 10:31AM |
$0.008 |
$0.006 |
fallen by
25%
|
|
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Oct 2024 10:31AM |
$0.011 |
$0.006 |
fallen by
45.45%
|
|
ID8 - Price-sensitive ASX Announcement
Full Release
Key Points
- USPTO rejected JP Morgan Chase challenges to the validity of Identitii’s patent
- Sales activities to progress new customer opportunities increased 260% q/o/q
- Go-to-market plan to expand into the United States has progressed
- Fully subscribed Rights Issue raised a total of $2.15M
- Payments to suppliers & employees of $1.28M, down 10% q/o/q
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Western Exploration Limited (GTE) ORDINARY FULLY PAID |
Materials |
$11 |
Application for quotation of securities - GTE
|
30 Oct 2024 10:30AM |
$0.035 |
$0.020 |
fallen by
42.86%
|
|
| Rex Minerals Limited (RXM) ORDINARY FULLY PAID |
Materials |
- |
Notification of cessation of securities - RXM
|
30 Oct 2024 10:30AM |
$0.465 |
$0.465 |
fallen by
0%
|
|
| Rex Minerals Limited (RXM) ORDINARY FULLY PAID |
Materials |
- |
Notification of cessation of securities - RXM
|
30 Oct 2024 10:30AM |
$0.465 |
$0.465 |
fallen by
0%
|
|
| Rex Minerals Limited (RXM) ORDINARY FULLY PAID |
Materials |
- |
Scheme Implementation
|
30 Oct 2024 10:30AM |
$0.465 |
$0.465 |
fallen by
0%
|
|
| Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$74 |
Reinstatement to Quotation
|
30 Oct 2024 10:28AM |
$0.003 |
$0.030 |
risen by
1,100%
|
|
GCM - Price-sensitive ASX Announcement
Full Release
Key Points
- GCM's trading suspension lifted immediately
- Announcement related to an acquisition
- Reinstatement to quotation on ASX
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$74 |
Acquisition of Advanced Groundbreaking Graphite Technology
|
30 Oct 2024 10:28AM |
$0.003 |
$0.030 |
risen by
1,100%
|
|
GCM - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of technology to produce VHD Graphite for various industrial applications.
- VHD Graphite exhibits record thermal conductivity of 617 W/m·K.
- Electrical resistivity of VHD Graphite is the lowest ever recorded for bulk graphite.
- Manufacturing process allows production in 24-36 hours compared to traditional methods.
- No specialized infrastructure required, making it cost-effective.
- GCM plans to move VHD Graphite into production within 12 months.
- Potential applications include heat sinks, batteries, and nuclear industries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EBOS Group Limited (EBO) ORDINARY FULLY PAID |
Health Care |
$7,365 |
FY 2024 Climate Statement
|
30 Oct 2024 10:28AM |
$33.410 |
$36.240 |
risen by
8.47%
|
|
| Ark Mines Limited (AHK) ORDINARY FULLY PAID |
Materials |
$14 |
Quarterly Appendix 5B Cash Flow Report
|
30 Oct 2024 10:24AM |
$0.190 |
$0.210 |
risen by
10.53%
|
|
AHK - Price-sensitive ASX Announcement
Full Release
Key Points
- Ark Mines Ltd reported a net cash from operating activities of A$688,000.
- The cash balance at the end of the period was A$641,000.
- Significant payments were made for administration and exploration costs.
- The company plans to conduct a capital raising in the next quarter.
- The report highlights a decrease in cash position compared to the previous quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Duxton Farms Ltd (DBF) ORDINARY FULLY PAID |
Consumer Staple |
$41 |
Notice of Annual General Meeting/Proxy Form
|
30 Oct 2024 10:24AM |
$1.435 |
$0.990 |
fallen by
31.01%
|
|
| Ark Mines Limited (AHK) ORDINARY FULLY PAID |
Materials |
$14 |
Quarterly Activities Report
|
30 Oct 2024 10:23AM |
$0.190 |
$0.210 |
risen by
10.53%
|
|
AHK - Price-sensitive ASX Announcement
Full Release
Key Points
- Operations highlighted by an expanded Exploration Target for Sandy Mitchell.
- Updated Measured Mineral Resource Estimate exceeded expectations.
- Sandy Mitchell's potential for world-class scale in rare earths.
- Upcoming Scoping Study and Pre-Feasibility Study planned.
- Mineral Resource Estimate includes high-value heavy minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carbonxt Group Limited (CG1) ORDINARY FULLY PAID |
Materials |
$28 |
Chairman's Address to AGM
|
30 Oct 2024 10:21AM |
$0.060 |
$0.068 |
risen by
13.33%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$20,450 |
Application for quotation of securities - COH
|
30 Oct 2024 10:20AM |
$283.610 |
$312.710 |
risen by
10.26%
|
|
| Hydrocarbon Dynamics Limited (HCD) ORDINARY FULLY PAID |
Energy |
$3 |
Quarterly Activities Report
|
30 Oct 2024 10:19AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
HCD - Price-sensitive ASX Announcement
Full Release
Key Points
- Ongoing sales and trials of HCD Multi-Flow products continue.
- Rights Issue announced to raise approximately $800,000.
- Evaluation of new investment opportunities in upstream energy and technology sectors.
- Successful treatment applications in Australia and Canada.
- Review of product supply in South Sudan due to ownership changes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$105 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Oct 2024 10:19AM |
$0.135 |
$0.270 |
risen by
100%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 2a trial of narmafotinib for pancreatic cancer completed first cohort of 26 patients.
- Six confirmed partial responses observed, indicating sufficient drug activity.
- Recruitment for an additional 24 patients has resumed.
- Narmafotinib received Fast Track Designation from US FDA.
- Key patent for narmafotinib granted in Europe and Japan.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$20,450 |
Application for quotation of securities - COH
|
30 Oct 2024 10:16AM |
$283.880 |
$312.710 |
risen by
10.16%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
